Selectivity in the Formation of Straight-Chain Versus Cyclised Products on Knoevenagel Condensation Between Thiobarbituric Acid and Naphthaldehydes

Abstract

The prevalence of Clostridium difficile (CD) infection has grown rapidly due to resistance and the emergence of new, highly virulent strains of the organism that have become less sensitive to many antibiotics. Vancomycin and metronidazole are front-line treatments of CD infection that still show good efficacy, but their effectiveness has declined for the treatment of recurrent infection and less sensitive strains of CD. More recently, the macrolide antibiotic fidaxomicin been introduced in the treatment of CD infection. Its high cost and limited usefulness against recurrent infection has prompted the search for new, narrow spectrum agents. We identified the CD dihydroorotate dehydrogenase (DHODase) as a potential enzyme target for the design of Knoevenagel products formed from reaction of 2-thiobarbituric acid and naphthaldehyde substrates. The presence of a hydroxyl substituent at position C2 in the naphthaldehyde ring offers the possibility to form the Knoevenagel product and to cyclize to give the tetracyclic, oxadeazaflavine with benzo-homologation. In this work, the selectivity for straight-chain formation over competing cyclisation on Knoevenagel condensation between thiobarbituric acid and naphthaldehyde substrates was examined. The outcomes of uncatalyzed condensations in refluxing ethanol were investigated by various methods including high field 1H and 13C NMR. Unsubstituted naphthaldehyde and its 2-methoxyl derivative favored straight-chain product formation whereas use of 2-hydroxynaphthaldehyde favored cyclisation and concomitant Michael addition of a second molecule of the corresponding acid to the newly formed exocyclic C=C bond. The pattern of reactivity was mirrored in the benzaldehyde series where the presence of the 2-hydroxyl function led to cyclized products with concomitant formation of the Michael adducts. The Knoevenagel products and the benzo-homologated oxadeazaflavine derivatives are candidates for evaluation as potential growth inhibitors of CD.

Publication DOI: https://doi.org/10.52711/0974-360X.2021.00852
Divisions: College of Health & Life Sciences > Aston Pharmacy School
College of Health & Life Sciences
Uncontrolled Keywords: Clostridium difficile,Knoevenagel Condensation,Naphthaldehyde,Thiobarbituric acid,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmacology (medical)
Full Text Link:
Related URLs: https://rjptonl ... ID=2021-14-9-66 (Publisher URL)
http://www.scop ... tnerID=8YFLogxK (Scopus URL)
PURE Output Type: Article
Published Date: 2021-09-01
Accepted Date: 2021-01-30
Authors: Fraser, William (ORCID Profile 0000-0001-6588-0166)
Haddad, Abdullah

Download

[img]

Version: Accepted Version

Access Restriction: Restricted to Repository staff only


Export / Share Citation


Statistics

Additional statistics for this record